Skip to main content
. 2022 Feb 15;66(2):e00916-21. doi: 10.1128/aac.00916-21

FIG 2.

FIG 2

Virologic response (<50 copies/mL) by the time to loss of virologic response (TLOVR) approach over time; intent to treat population. B, baseline; CI, confidence interval; q.d., once daily; RPV, rilpivirine.